TP53 and neoplasm: Critically, E6 and E7 promote the proteasomal degradation of the p53 and pRb tumour suppressors, by co-opting the E3 ligases E6-associated protein (E6-AP) and a Cullin-2 ubiquitin ligase complex [22–24].